Australia Patent: Neurimmune Holding, Mabimmune Diagnostics, University of Zurich File Application for 'Novel anti-Fibroblast Activation Protein (FAP) antibodies and uses derived thereof'

Press/Media: Expert Comment

Period15 Jul 2017

Media coverage

1

Media coverage

  • TitleAustralia Patent: Neurimmune Holding, Mabimmune Diagnostics, University of Zurich File Application for 'Novel anti-Fibroblast Activation Protein (FAP) antibodies and uses derived thereof'
    Media name/outletAustralian Government News (Ht Media)
    CountryAustralia
    Date15/07/17
    PersonsSimon P. Hoerstrup